Nuveen Asset Management, LLC Elevation Oncology, Inc. Transaction History

Nuveen Asset Management, LLC

  • $340 Billion
  • Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 174,137 shares of ELEV stock, worth $62,689. This represents 0.0% of its overall portfolio holdings.

Number of Shares
174,137
Previous 174,137 -0.0%
Holding current value
$62,689
Previous $104,000 3.85%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.56 - $3.02 $52,052 - $280,709
92,950 Added 114.49%
174,137 $104,000
Q2 2024

Aug 09, 2024
BUY
$2.35 - $5.17 $190,789 - $419,736
81,187 New
81,187 $219,000

Others Institutions Holding ELEV

# of Institutions
5
Shares Held
2.68M
Call Options Held
0
Put Options Held
0
View Full List

About Elevation Oncology, Inc.

ELEV Quotes by TradingView
  • Ticker ELEV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,300,900
  • Market Cap $8.39M
  • Description
  • Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...
More about ELEV
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email